Tech & Science
The medication is an adeno-associated viral (AAV) vector-based gene therapy drug for the treatment of adults (aged 18 years or older) with moderately severe...
Hi, what are you looking for?
The medication is an adeno-associated viral (AAV) vector-based gene therapy drug for the treatment of adults (aged 18 years or older) with moderately severe...
Novel pharmacokinetic modelling techniques enable haemophilia treaters, and their patients, to make optimal decisions.
The thirteen patients were given the gene therapy at Barts Health NHS Trust, in the U.K. Eleven of the patients are now producing normal...
A discovery was made in late 2015, and now recently reported, concerning a Japanese company called the Chemo-Sero-Therapeutic Research Institute (Kaketsuken), based in Kumamoto....